Affimed N.V. (AFMD)
After hours:
| Previous Close | 6.58 |
| Open | 6.66 |
| Bid | 6.06 x 1400 |
| Ask | 6.70 x 1000 |
| Day's Range | 5.95 - 6.66 |
| 52 Week Range | 4.78 - 11.74 |
| Volume | |
| Avg. Volume | 1,662,385 |
| Market Cap | 722.045M |
| Beta (5Y Monthly) | 2.65 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.59 |
| Earnings Date | Nov. 08, 2021 - Nov. 12, 2021 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 14.76 |
- Simply Wall St.
Could The Affimed N.V. (NASDAQ:AFMD) Ownership Structure Tell Us Something Useful?
A look at the shareholders of Affimed N.V. ( NASDAQ:AFMD ) can tell us which group is most powerful. Generally...
- Motley Fool
3 Best Biopharma Stocks to Buy During This Industrywide Fire Sale
Biopharmaceutical stocks are slated to end the year on a sour note. This industrywide sell-off has also picked up momentum during the waning days of Nov., with an eye-popping 358 biopharma stocks falling by more than 10% during just the past three weeks. Savvy investors, though, know that steep drops in the market typically represent compelling buying opportunities.
- Motley Fool
Why Affimed Stock Is On Fire Today
What happened Shares of the German cancer immunotherapy company Affimed (NASDAQ: AFMD) jumped by as much as 25% in premarket trading Monday morning. The biotech's stock is popping in early morning action today in response to overwhelmingly positive early-stage trial results for its lead product candidate, AFM13.
